INSM INSMED Inc
Nasdaq · SEC CIK 1104506 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $167.12M 59 sales by 10 insiders
- Filings on record
- 317 since 2021-07-09, latest 2026-09-11 16:04
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Adsett Roger | COO | — | $48.25M |
| Lewis William | COB, CEO, Dir | — | $32.79M |
| Flammer Martina M.D. | Chief Medical Off | — | $23.32M |
| Schaeffer Orlov S Nicole | Chief People Strategy Off | — | $21.11M |
| LEE LEO | Dir | — | $14.69M |
| Smith Michael Alexander | CLO | — | $14.00M |
| SHAROKY MELVIN MD | Dir | — | $4.74M |
| Brennan David R | Dir | — | $3.10M |
| ANDERSON ELIZABETH M | Dir | — | $2.98M |
| Bonstein Sara | CFO | — | $2.13M |
Transactions 475
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-03-19 | 2025-03-17 | INSM | Lewis William | COB, CEO, Dir | S - Sale+OE | $77.03 | -18.8K | 334.2K | -5% | -$1.44M |
| DMI | 2025-03-19 | 2025-03-17 | INSM | Lewis William | COB, CEO, Dir | S - Sale+OE | $77.04 | -6,830 | 236.7K | -3% | -$526.2K |
| DI | 2025-03-19 | 2025-03-17 | INSM | Lewis William | COB, CEO, Dir | M - OptEx | $10.85 | +6,830 | 240.8K | +3% | +$74.1K |
| D | 2025-03-05 | 2025-03-03 | INSM | Lewis William | COB, CEO, Dir | M - OptEx | $22.76 | +18.8K | 352.9K | +6% | +$426.8K |
| DM | 2025-03-05 | 2025-03-03 | INSM | Lewis William | COB, CEO, Dir | S - Sale+OE | $77.79 | -18.8K | 334.2K | -5% | -$1.46M |
| DMI | 2025-03-05 | 2025-03-03 | INSM | Lewis William | COB, CEO, Dir | S - Sale+OE | $77.79 | -6,830 | 234.0K | -3% | -$531.3K |
| DI | 2025-03-05 | 2025-03-03 | INSM | Lewis William | COB, CEO, Dir | M - OptEx | $10.85 | +6,830 | 240.8K | +3% | +$74.1K |
| MI | 2025-02-27 | 2025-02-25 | INSM | SHAROKY MELVIN MD | Dir | G - Gift | $0.00 | +1,443 | 4,764 | +43% | $0 |
| 2025-02-27 | 2025-02-25 | INSM | SHAROKY MELVIN MD | Dir | G - Gift | $0.00 | -1,443 | 296.7K | -0.5% | $0 | |
| M | 2025-02-20 | 2025-02-18 | INSM | Bonstein Sara | CFO | S - Sale | $80.31 | -18.3K | 118.9K | -13% | -$1.47M |
| DMI | 2025-02-20 | 2025-02-18 | INSM | Lewis William | COB, CEO, Dir | S - Sale+OE | $81.03 | -6,830 | 233.9K | -3% | -$553.4K |
| DM | 2025-02-20 | 2025-02-18 | INSM | Lewis William | COB, CEO, Dir | S - Sale+OE | $81.03 | -18.8K | 334.9K | -5% | -$1.52M |
| D | 2025-02-20 | 2025-02-18 | INSM | Lewis William | COB, CEO, Dir | M - OptEx | $22.76 | +18.8K | 352.9K | +6% | +$426.8K |
| DI | 2025-02-20 | 2025-02-18 | INSM | Lewis William | COB, CEO, Dir | M - OptEx | $10.85 | +6,830 | 240.8K | +3% | +$74.1K |
| M | 2025-02-13 | 2025-02-11+ | INSM | Bonstein Sara | CFO | S - Sale | $80.00 | -18.3K | 137.2K | -12% | -$1.47M |
| M | 2025-02-12 | 2025-02-10 | INSM | Adsett Roger | COO | S - Sale | $78.61 | -43.0K | 172.2K | -20% | -$3.38M |
| M | 2025-02-12 | 2025-02-10 | INSM | Flammer Martina M.D. | Chief Medical Off | S - Sale | $78.61 | -37.8K | 128.3K | -23% | -$2.97M |
| M | 2025-02-07 | 2025-02-06+ | INSM | Adsett Roger | COO | S - Sale | $80.90 | -45.7K | 189.2K | -19% | -$3.70M |
| 2025-02-07 | 2025-02-05 | INSM | Adsett Roger | COO | A - Grant | $0.00 | +88.7K | 234.8K | +61% | $0 | |
| 2025-02-07 | 2025-02-05 | INSM | Lewis William | COB, CEO, Dir | A - Grant | $0.00 | +153.7K | 533.2K | +40% | $0 | |
| 2025-02-07 | 2025-02-06 | INSM | Lewis William | COB, CEO, Dir | S - Sale | $80.90 | -79.3K | 453.9K | -15% | -$6.42M | |
| M | 2025-02-07 | 2025-02-06+ | INSM | Flammer Martina M.D. | Chief Medical Off | S - Sale | $80.90 | -33.1K | 138.1K | -19% | -$2.68M |
| 2025-02-07 | 2025-02-05 | INSM | Flammer Martina M.D. | Chief Medical Off | A - Grant | $0.00 | +70.9K | 171.1K | +71% | $0 | |
| M | 2025-02-07 | 2025-02-06+ | INSM | Wise John Drayton | Chief Commercial Off | S - Sale | $80.90 | -7,920 | 133.0K | -6% | -$640.7K |
| 2025-02-07 | 2025-02-05 | INSM | Wise John Drayton | Chief Commercial Off | A - Grant | $0.00 | +15.4K | 140.9K | +12% | $0 | |
| 2025-02-07 | 2025-02-05 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Off | A - Grant | $0.00 | +47.3K | 144.4K | +49% | $0 | |
| 2025-02-07 | 2025-02-06 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Off | S - Sale | $80.90 | -23.5K | 120.9K | -16% | -$1.90M | |
| 2025-02-07 | 2025-02-05 | INSM | Bonstein Sara | CFO | A - Grant | $0.00 | +65.0K | 183.9K | +55% | $0 | |
| 2025-02-07 | 2025-02-06 | INSM | Bonstein Sara | CFO | S - Sale | $80.90 | -28.4K | 155.5K | -15% | -$2.30M | |
| 2025-02-07 | 2025-02-05 | INSM | Smith Michael Alexander | CLO | A - Grant | $0.00 | +47.3K | 117.3K | +68% | $0 | |
| 2025-02-07 | 2025-02-06 | INSM | Smith Michael Alexander | CLO | S - Sale | $80.90 | -20.6K | 96.6K | -18% | -$1.67M | |
| DM | 2025-02-05 | 2025-02-03 | INSM | Lewis William | COB, CEO, Dir | S - Sale+OE | $77.94 | -18.8K | 379.5K | -5% | -$1.46M |
| DI | 2025-02-05 | 2025-02-03 | INSM | Lewis William | COB, CEO, Dir | M - OptEx | $10.85 | +6,830 | 240.8K | +3% | +$74.1K |
| DMI | 2025-02-05 | 2025-02-03 | INSM | Lewis William | COB, CEO, Dir | S - Sale+OE | $77.94 | -6,830 | 233.9K | -3% | -$532.3K |
| D | 2025-02-05 | 2025-02-03 | INSM | Lewis William | COB, CEO, Dir | M - OptEx | $22.76 | +18.8K | 398.3K | +5% | +$426.8K |
| DM | 2025-01-31 | 2025-01-30 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Off | M - OptEx | $15.04 | +91.1K | 188.2K | +94% | +$1.37M |
| D | 2025-01-31 | 2025-01-30 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Off | S - Sale+OE | $80.00 | -91.1K | 97.1K | -48% | -$7.29M |
| 2025-01-16 | 2025-01-14 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Off | S - Sale | $68.72 | -872 | 97.1K | -0.9% | -$59.9K | |
| 2025-01-16 | 2025-01-14 | INSM | Adsett Roger | COO | S - Sale | $68.72 | -1,457 | 146.1K | -1.0% | -$100.1K | |
| 2025-01-16 | 2025-01-14 | INSM | Flammer Martina M.D. | Chief Medical Off | S - Sale | $68.72 | -1,384 | 100.2K | -1% | -$95.1K | |
| DMI | 2025-01-16 | 2025-01-15 | INSM | Lewis William | COB, CEO, Dir | S - Sale+OE | $70.17 | -6,830 | 239.3K | -3% | -$479.3K |
| DI | 2025-01-16 | 2025-01-15 | INSM | Lewis William | COB, CEO, Dir | M - OptEx | $10.85 | +6,830 | 240.8K | +3% | +$74.1K |
| DM | 2025-01-16 | 2025-01-15 | INSM | Lewis William | COB, CEO, Dir | S - Sale+OE | $70.18 | -31.8K | 382.0K | -8% | -$2.23M |
| D | 2025-01-16 | 2025-01-15 | INSM | Lewis William | COB, CEO, Dir | M - OptEx | $22.76 | +18.8K | 411.3K | +5% | +$426.8K |
| DM | 2025-01-10 | 2025-01-07+ | INSM | Smith Michael Alexander | CLO | S - Sale | $65.82 | -3,689 | 64.6K | -5% | -$242.8K |
| D | 2025-01-10 | 2025-01-08 | INSM | Smith Michael Alexander | CLO | A - Grant | — | +5,706 | 70.3K | +9% | — |
| DM | 2025-01-10 | 2025-01-07+ | INSM | Adsett Roger | COO | S - Sale | $64.78 | -9,228 | 145.8K | -6% | -$597.8K |
| D | 2025-01-10 | 2025-01-08 | INSM | Adsett Roger | COO | A - Grant | — | +6,657 | 152.4K | +5% | — |
| D | 2025-01-10 | 2025-01-08 | INSM | Lewis William | COB, CEO, Dir | A - Grant | — | +22.8K | 395.6K | +6% | — |
| DM | 2025-01-10 | 2025-01-07+ | INSM | Lewis William | COB, CEO, Dir | S - Sale | $65.48 | -15.2K | 392.6K | -4% | -$995.0K |
| DM | 2025-01-10 | 2025-01-07+ | INSM | Bonstein Sara | CFO | S - Sale | $65.43 | -6,000 | 118.9K | -5% | -$392.6K |
| D | 2025-01-10 | 2025-01-08 | INSM | Bonstein Sara | CFO | A - Grant | — | +6,657 | 119.9K | +6% | — |
| D | 2025-01-10 | 2025-01-07 | INSM | Wise John Drayton | Chief Commercial Off | M - OptEx | $16.07 | +10.0K | 132.5K | +8% | +$160.7K |
| DM | 2025-01-10 | 2025-01-07+ | INSM | Wise John Drayton | Chief Commercial Off | S - Sale+OE | $65.95 | -13.6K | 119.6K | -10% | -$896.1K |
| D | 2025-01-10 | 2025-01-08 | INSM | Wise John Drayton | Chief Commercial Off | A - Grant | — | +6,657 | 125.8K | +6% | — |
| DM | 2025-01-10 | 2025-01-07+ | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Off | S - Sale | $64.74 | -7,862 | 97.5K | -7% | -$509.0K |
| D | 2025-01-10 | 2025-01-08 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Off | A - Grant | — | +5,706 | 102.0K | +6% | — |
| DM | 2025-01-10 | 2025-01-07+ | INSM | Flammer Martina M.D. | Chief Medical Off | S - Sale | $64.70 | -11.2K | 101.5K | -10% | -$725.8K |
| D | 2025-01-10 | 2025-01-08 | INSM | Flammer Martina M.D. | Chief Medical Off | A - Grant | — | +6,657 | 107.7K | +7% | — |
| D | 2025-01-03 | 2025-01-02 | INSM | Lewis William | COB, CEO, Dir | M - OptEx | $22.76 | +18.8K | 403.7K | +5% | +$426.8K |
| DI | 2025-01-03 | 2025-01-02 | INSM | Lewis William | COB, CEO, Dir | M - OptEx | $10.85 | +6,830 | 240.8K | +3% | +$74.1K |
| DI | 2025-01-03 | 2025-01-02 | INSM | Lewis William | COB, CEO, Dir | S - Sale+OE | $69.86 | -6,830 | 233.9K | -3% | -$477.1K |
| D | 2025-01-03 | 2025-01-02 | INSM | Lewis William | COB, CEO, Dir | S - Sale+OE | $69.84 | -18.8K | 385.0K | -5% | -$1.31M |
| DM | 2024-12-20 | 2024-12-19 | INSM | Lewis William | COB, CEO, Dir | S - Sale+OE | $69.91 | -18.8K | 390.5K | -5% | -$1.31M |
| DMI | 2024-12-20 | 2024-12-19 | INSM | Lewis William | COB, CEO, Dir | S - Sale+OE | $69.92 | -6,830 | 235.5K | -3% | -$477.6K |
| D | 2024-12-20 | 2024-12-19 | INSM | Lewis William | COB, CEO, Dir | M - OptEx | $22.76 | +18.8K | 403.7K | +5% | +$426.8K |
| DI | 2024-12-20 | 2024-12-19 | INSM | Lewis William | COB, CEO, Dir | M - OptEx | $10.85 | +6,830 | 240.8K | +3% | +$74.1K |
| DMI | 2024-12-13 | 2024-12-12 | INSM | Lewis William | COB, CEO, Dir | S - Sale+OE | $72.98 | -6,830 | 236.7K | -3% | -$498.5K |
| DM | 2024-12-13 | 2024-12-12 | INSM | Lewis William | COB, CEO, Dir | S - Sale+OE | $72.97 | -18.8K | 385.0K | -5% | -$1.37M |
| D | 2024-12-13 | 2024-12-12 | INSM | Lewis William | COB, CEO, Dir | M - OptEx | $22.76 | +18.8K | 403.7K | +5% | +$426.8K |
| DI | 2024-12-13 | 2024-12-12 | INSM | Lewis William | COB, CEO, Dir | M - OptEx | $10.85 | +6,830 | 240.8K | +3% | +$74.1K |
| DM | 2024-09-16 | 2024-09-12+ | INSM | Flammer Martina M.D. | Chief Medical Off | S - Sale+OE | $74.91 | -41.0K | 106.1K | -28% | -$3.07M |
| DM | 2024-09-16 | 2024-09-12+ | INSM | Flammer Martina M.D. | Chief Medical Off | M - OptEx | $34.03 | +41.0K | 119.6K | +52% | +$1.40M |
| D | 2024-09-16 | 2024-09-13 | INSM | Smith Michael Alexander | CLO | M - OptEx | $22.76 | +7,000 | 95.7K | +8% | +$159.3K |
| DM | 2024-09-16 | 2024-09-13 | INSM | Smith Michael Alexander | CLO | S - Sale+OE | $74.35 | -27.9K | 76.9K | -27% | -$2.07M |
| DM | 2024-09-10 | 2024-09-06 | INSM | Flammer Martina M.D. | Chief Medical Off | M - OptEx | $22.77 | +149.0K | 235.7K | +172% | +$3.39M |
| DM | 2024-09-10 | 2024-09-06 | INSM | Flammer Martina M.D. | Chief Medical Off | S - Sale+OE | $71.23 | -149.0K | 115.2K | -56% | -$10.61M |
| D | 2024-09-10 | 2024-09-10 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Off | M - OptEx | $10.85 | +37.6K | 137.7K | +38% | +$407.7K |
| DM | 2024-09-10 | 2024-09-10 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Off | S - Sale+OE | $71.50 | -37.6K | 109.7K | -26% | -$2.69M |
| I | 2024-09-03 | 2024-08-29 | INSM | SHAROKY MELVIN MD | Dir | G - Gift | $0.00 | +10.0K | 17.7K | +130% | $0 |
| 2024-09-03 | 2024-08-29 | INSM | SHAROKY MELVIN MD | Dir | G - Gift | $0.00 | -10.0K | 298.2K | -3% | $0 | |
| 2024-08-14 | 2024-08-12 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Off | S - Sale | $72.49 | -9,469 | 100.1K | -9% | -$686.4K | |
| DM | 2024-08-14 | 2024-08-12 | INSM | Smith Michael Alexander | CLO | M - OptEx | $15.59 | +88.1K | 176.8K | +99% | +$1.37M |
| DM | 2024-08-14 | 2024-08-12 | INSM | Smith Michael Alexander | CLO | S - Sale+OE | $72.96 | -88.1K | 88.7K | -50% | -$6.43M |
| 2024-07-10 | 2024-07-08 | INSM | Smith Michael Alexander | CLO | F - Tax | $70.05 | -730 | 88.7K | -0.8% | -$51.1K | |
| D | 2024-06-12 | 2024-06-10 | INSM | Flammer Martina M.D. | Chief Medical Off | S - Sale+OE | $60.00 | -21.2K | 106.1K | -17% | -$1.27M |
| D | 2024-06-12 | 2024-06-10 | INSM | Flammer Martina M.D. | Chief Medical Off | M - OptEx | $23.75 | +21.2K | 127.3K | +20% | +$503.4K |
| DM | 2024-06-05 | 2024-06-03 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Off | M - OptEx | $21.09 | +55.0K | 122.5K | +81% | +$1.16M |
| D | 2024-06-05 | 2024-06-03 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Off | S - Sale+OE | $55.33 | -55.0K | 108.8K | -34% | -$3.04M |
| D | 2024-05-30 | 2024-05-28 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Off | M - OptEx | $12.58 | +27.5K | 136.3K | +25% | +$345.9K |
| D | 2024-05-30 | 2024-05-28 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Off | S - Sale+OE | $49.53 | -27.5K | 108.8K | -20% | -$1.36M |
| DM | 2024-05-30 | 2024-05-28+ | INSM | Bonstein Sara | CFO | M - OptEx | $26.55 | +241.3K | 323.2K | +295% | +$6.41M |
| DM | 2024-05-30 | 2024-05-28+ | INSM | Bonstein Sara | CFO | S - Sale+OE | $50.00 | -241.3K | 117.5K | -67% | -$12.06M |
| DM | 2024-05-30 | 2024-05-28 | INSM | Wise John Drayton | Chief Commercial Off | S - Sale+OE | $49.79 | -7,852 | 121.7K | -6% | -$390.9K |
| D | 2024-05-30 | 2024-05-28 | INSM | Wise John Drayton | Chief Commercial Off | M - OptEx | $12.58 | +6,250 | 127.9K | +5% | +$78.6K |
| DM | 2024-05-30 | 2024-05-28+ | INSM | Flammer Martina M.D. | Chief Medical Off | S - Sale+OE | $50.53 | -125.0K | 106.1K | -54% | -$6.32M |
| DM | 2024-05-30 | 2024-05-28+ | INSM | Flammer Martina M.D. | Chief Medical Off | M - OptEx | $23.68 | +125.0K | 209.9K | +147% | +$2.96M |
| DM | 2024-05-30 | 2024-05-28 | INSM | Smith Michael Alexander | CLO | M - OptEx | $14.27 | +39.0K | 111.6K | +54% | +$556.1K |
| D | 2024-05-30 | 2024-05-28 | INSM | Smith Michael Alexander | CLO | S - Sale+OE | $49.53 | -44.7K | 88.8K | -33% | -$2.22M |
| 2024-05-17 | 2024-05-17 | INSM | Adsett Roger | COO | S - Sale | $25.09 | -5,945 | 149.3K | -4% | -$149.2K |
Purchase Sale Sale after option exercise All abbreviations